FindTrial
Sign In

Development and preliminary application of a method for determination of plasma trough concentration of oral targeted drugs for liver cancer

Development and preliminary application of a method for determination of plasma trough concentration of oral targeted drugs for liver cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081294
Enrollment
Unknown
Registered
2024-02-28
Start date
2024-03-01
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver cancer

Interventions

Single arm:Blood will be collected

Sponsors

Changzhou Tumor Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Volunteer to participate in clinical trials and sign informed consent forms. 2.Age above 18(inclusive) , below 80(inclusive) . 3.Liver cancer patients diagnosed histologically and/or cytologically. 4.Planning or using oral targeted drugs for liver cancer.

Exclusion criteria

Exclusion criteria: 1.Participants in clinical trials of other registered drugs. 2.The presence of severe psychological or psychiatric abnormalities affected the participants' compliance to participate in this clinical study. 3.According to the judgment of the researcher, there are other conditions that are not suitable for participating in this study.

Design outcomes

Primary

MeasureTime frame
Drug concentration in plasma;—

Countries

China

Contacts

Public ContactGuangzhao He

Changzhou Tumor Hospital

shmily_hgzhao@hotmail.com+86 158 9507 7179

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026